Skip to content

Cardurion Pharmaceuticals vs InterCure

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

Translating the science of cardiac myocyte signaling pathways into groundbreaking therapeutics

80 employees · est. 2017 · Burlington, United States

VS
InterCure logo

InterCure

Harness the power of respiratory-based treatment for hypertension and heart failure with innovative non-drug solutions

est. 1994

InterCure is the older company (2017 vs 1994).

Side-by-Side Comparison

Cardurion Pharmaceuticals InterCure
Founded
2017 1994 older
Headquarters
Burlington, United States Not tracked yet
Employees
80 Not tracked yet
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Series B Post-IPO Equity
Total Funding
$603.20M $41.90M
Funding Rounds
5 6
Services
Research and Development of Cardiovascular Drugs, Clinical Programs in PDE9 and CaMKII, In-house Drug Discovery, Clinical Study Evaluation Not tracked yet
Target Customers
Patients with Cardiovascular Disease, Healthcare Providers, Pharmaceutical Companies, Biotechnology Investors Not tracked yet
Taxonomy
Cardurion PharmaceuticalsCardiac Myocyte Signaling PathwaysPDE9 InhibitionCaMKII InhibitionCardiovascular TherapeuticsHeart Failure Treatment +10 Respiratory-based TreatmentCardiovascular DiseasesPulmonary DiseasesNon-drug TreatmentsHypertensionHeart Failure +8
Website
cardurion.com intercure.com
Cardurion Pharmaceuticals logo

About Cardurion Pharmaceuticals

Cardurion Pharmaceuticals, founded in 2017, is a biotechnology and pharmaceutical company targeting advancements in cardiovascular health through innovative drug discovery. The company is renowned for its expertise in translating cardiac myocyte signaling pathways into groundbreaking therapeutics, s...

InterCure logo

About InterCure

InterCure is a medical device company founded in 1994 that focuses on respiratory-based methods for treating cardiovascular and pulmonary diseases. The company's flagship product, RESpeRATE, is the only FDA-cleared device clinically proven to lower high blood pressure without side effects. In additi...

Also comparing in this category

Comparing more than these two?

Get Cardurion Pharmaceuticals, InterCure and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Cardurion Pharmaceuticals compare?

A PDF of Cardurion Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Cardurion Pharmaceuticals was founded in 2017, based in Burlington, United States, with 80 employees. Cardurion Pharmaceuticals, founded in 2017, is a biotechnology and pharmaceutical company targeting advancements in cardiovascular health through innovative drug discovery. The company is renowned for. InterCure was founded in 1994. InterCure is a medical device company founded in 1994 that focuses on respiratory-based methods for treating cardiovascular and pulmonary diseases. The company's flagship product, RESpeRATE, is the on.
Cardurion Pharmaceuticals has raised $603.20M and InterCure $41.90M. Latest stage: Cardurion Pharmaceuticals Series B, InterCure Post-IPO Equity.
Both work in Biotechnology and Health Care and list cardiovascular diseases among their focus areas.

Compare Cardurion Pharmaceuticals with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cardurion Pharmaceuticals on 12 Sep 2024, and InterCure on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout